Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection

被引:4
|
作者
Niu, Nan [1 ,2 ]
He, Yuhui [1 ,2 ]
Mou, Yiping [2 ]
Meng, Sijia [2 ,3 ]
Xu, Peng [2 ,4 ]
Zhou, Yucheng [2 ]
Jin, Weiwei [2 ]
Lu, Chao [2 ]
Xu, Yunyun [2 ]
Zhu, Qicong [2 ]
Xia, Tao [2 ]
机构
[1] Zhejiang Chinese Med Univ, Second Clin Med Coll, Dept Surg, Hangzhou, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Canc Ctr,Department of Gen Surg,Div Gastrointestin, Hangzhou, Peoples R China
[3] Bengbu Med Coll, Dept Surg, Bengbu, Peoples R China
[4] Qingdao Univ, Dept Surg, Qingdao, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
pancreatic cancer; laparoscopic distal pancreatosplenectomy; laparoscopic RAMPS; chemotherapy; survivability;
D O I
10.3389/fsurg.2022.981591
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Laparoscopic radical antegrade modular pancreatosplenectomy (LRAMPS) is a validated surgical treatment for patients with left-sided pancreatic ductal adenocarcinoma (PDAC). In addition, laparoscopic distal pancreatectomy (LDPS) has purported benefits. However, there is a limited analysis comparing the results between LRAMPS and LDPS. Thus, this study aims to compare the short-term and long-term outcomes of patients who underwent LRAMPS and LDPS for PDAC treatment. Methods: Patients with left-sided PDAC that underwent LRAMPS or LDPS from 2015 to 2021 were retrospectively identified. Demographic and clinic pathologic data were collected. Disease-free survival (DFS) and overall survival (OS) probabilities were obtained. Results: The number of lymph nodes retrieved was significantly greater in the LRAMPS group than in the LDPS group. Several clinicopathological factors, including CA19-9 levels greater than 37 U/ml, positive lymph nodes, moderate to poor tumor differentiation, and peripancreas fat invasion, were associated with DFS. Moderate with poor tumor differentiation was associated with poor DFS (HR 0.568; 95% CI 0.373-0.921; P = 0.021). Levels of CA19-9 greater than 37 U/ml, CEA levels greater than 5 mu g/ml, larger tumor size, positive lymph nodes, moderate with poor tumor differentiation, peripancreas fat invasion, and adjuvant chemotherapy were all associated with OS. LRAMPS nearly improved OS but did not reach statistical significance. Serum carcinoembryonic antigen (CEA) levels greater than 5 ug/ml (HR 1.693; 95% CI 1.200-1.132; P = 0.001), and positive lymph nodes (HR 2.410; 95% CI 1.453-3.995; P = 0.001) were independently associated with poor OS. Treatment with adjuvant chemotherapy was associated with improved OS (HR 0.491; 95% CI 0.248-0.708; P = 0.001). Conclusions: The LRAMPS procedure achieved comparable results to standard LDPS in terms of postoperative outcomes. Treatment with chemotherapy is important for the prognosis of patients with left-sided pancreatic cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma
    Menghua Dai
    Hanyu Zhang
    Yatong Li
    Cheng Xing
    Cheng Ding
    Quan Liao
    Taiping Zhang
    Junchao Guo
    Qiang Xu
    Xianlin Han
    Wenjing Liu
    Qiaofei Liu
    Surgery Today, 2021, 51 : 1126 - 1134
  • [2] Radical antegrade modular pancreatosplenectomy (RAMPS) versus conventional distal pancreatosplenectomy (CDPS) for left-sided pancreatic ductal adenocarcinoma
    Dai, Menghua
    Zhang, Hanyu
    Li, Yatong
    Xing, Cheng
    Ding, Cheng
    Liao, Quan
    Zhang, Taiping
    Guo, Junchao
    Xu, Qiang
    Han, Xianlin
    Liu, Wenjing
    Liu, Qiaofei
    SURGERY TODAY, 2021, 51 (07) : 1126 - 1134
  • [3] Laparoscopic radical antegrade modular pancreatosplenectomy vesus laparoscopic distal pancreatosplenectomy for left-sided pancreatic cancer: a systematic review and meta-analysis
    Jiang, Xutao
    Zhu, Yu
    Li, Jianwei
    Li, Wei
    Zheng, Weizong
    Xu, Caiming
    Zhang, Guixin
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [4] Laparoscopic subtotal pancreatectomy with radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer
    Kim, Seongho
    Yoon, Yoo-Seok
    Han, Ho-Seong
    Cho, Jai Young
    SURGICAL ONCOLOGY-OXFORD, 2019, 28 : 150 - 150
  • [5] Comparison of radical antegrade modular pancreatosplenectomy with standard pancreatosplenectomy for left sided pancreatic cancer
    Tarrar, Talha Azam
    Iqbal, Hafiz Muhammad Nuheel
    Sonoo, Prithvirao
    Karamat, Syed Taimur
    Khawaja, Amir
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [6] Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer using the ligament of Treitz approach
    Ome, Yusuke
    Hashida, Kazuki
    Yokota, Mitsuru
    Nagahisa, Yoshio
    Michio, Okabe
    Kawamoto, Kazuyuki
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (11): : 4836 - 4837
  • [7] Laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma
    Tamotsu Kuroki
    Susumu Eguchi
    Surgery Today, 2015, 45 : 808 - 812
  • [8] Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer using the ligament of Treitz approach
    Yusuke Ome
    Kazuki Hashida
    Mitsuru Yokota
    Yoshio Nagahisa
    Okabe Michio
    Kazuyuki Kawamoto
    Surgical Endoscopy, 2017, 31 : 4836 - 4837
  • [9] Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma
    Hirashita, Teijiro
    Iwashita, Yukio
    Fujinaga, Atsuro
    Nakanuma, Hiroaki
    Tada, Kazuhiro
    Masuda, Takashi
    Endo, Yuichi
    Ohta, Masayuki
    Inomata, Masafumi
    SURGERY TODAY, 2022, 52 (02) : 224 - 230
  • [10] Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma
    Teijiro Hirashita
    Yukio Iwashita
    Atsuro Fujinaga
    Hiroaki Nakanuma
    Kazuhiro Tada
    Takashi Masuda
    Yuichi Endo
    Masayuki Ohta
    Masafumi Inomata
    Surgery Today, 2022, 52 : 224 - 230